首页> 外文期刊>The International journal of clinical and experimental hypnosis >Methylphenidate Facilitates Hypnotizability in Adults With ADHD: A Naturalistic Cohort Study
【24h】

Methylphenidate Facilitates Hypnotizability in Adults With ADHD: A Naturalistic Cohort Study

机译:哌醋甲酯有助于成人多动症的催眠作用:一项自然队列研究

获取原文
获取原文并翻译 | 示例
       

摘要

Impaired attention may impede learning of adaptive skills in ADHD. While manipulations that reduce competition between attentional processes, including hypnosis, could boost learning, their feasibility in ADHD is unknown. Because hypnotic phenomena rely on attentional mechanisms, the authors aimed to assess whether stimulants could enhance hypnotizability in ADHD. In the current study, stimulant-naive patients seeking treatment for ADHD-related symptoms were assessed with the Stanford Hypnotic Susceptibility Scale (SHSS) at baseline and during methylphenidate treatment. Methylphenidate dose and SHSS increase were negatively correlated with baseline SHSS scores. Upon reaching effective doses, mean SHSS scores increased significantly. All patients who had been poorly hypnotizable at baseline demonstrated moderate-to-high hypnotizability at follow-up. The data support methylphenidate enhancement of hypnotizability in ADHD, thus highlighting novel treatment approaches for this disabling disorder.
机译:注意受损可能会阻碍ADHD适应能力的学习。虽然减少催眠等注意力过程之间的竞争的操作可以促进学习,但它们在多动症中的可行性尚不清楚。由于催眠现象依赖于注意力机制,因此作者旨在评估兴奋剂是否可以增强多动症的催眠作用。在当前的研究中,在基线和哌醋甲酯治疗期间,使用史丹佛催眠药敏量表(SHSS)评估了未接受过兴奋剂的多动症相关症状的初治患者。哌醋甲酯剂量和SHSS增加与基线SHSS评分呈负相关。达到有效剂量后,平均SHSS得分显着提高。基线时所有催眠作用较差的患者在随访中均表现出中度至高度催眠作用。数据支持哌醋甲酯增强多动症的催眠作用,因此突出了针对这种致残障碍的新型治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号